Abstract
Background: Stroke is one of the most burdensome neurological conditions affecting young and older adult populations worldwide, and notably it has remained one of the leading causes of disability and premature mortality within its disease category. Timely and accurate diagnosis and characterization of stroke with cross-sectional imaging impacts significantly on treatment planning and patient outcomes, particularly with the advent of early reperfusion therapies. Recently, there has been growing recognition that perfusion-weighted MRI (PW-MRI) may offer a significant advantage in diagnosing and characterizing the ischemia induced by stroke, as it can detect diffusion–perfusion deficits that may influence treatment decisions to prevent infarction. This structured literature review sought to explore the diagnostic utility and accuracy of PW-MRI compared to other MRI protocols.
Methods: A literature search was performed using Medline, Embase, and the Cochrane Library, with articles limited to the English language and publication in the last 15 years. Eligible articles were appraised using the QUADAS-2 framework, and given marked interstudy heterogeneity, the diagnostic outcomes were analyzed using a narrative approach.
Results: A total of ten studies were reviewed — retrospective and one prospective — and found to observe a moderate–high risk of bias. The studies revealed that PW-MRI offers beneficial diagnostic capabilities when compared to other MRI sequences and ability to detect significant diffusion–perfusion mismatches. However, PW-MRI was found to overestimate the degree of oligemia and ischemia in brain tissue. As ischemia does not always progress to infarction, thrombolytic treatment may be unnecessary in some cases and expose patients to adverse effects.
Conclusion: These findings indicate that PW-MRI should be considered for routine imaging as an adjunct to other MRI protocols and an alternative to CT thereby reducing ionizing radiation exposure.
Methods: A literature search was performed using Medline, Embase, and the Cochrane Library, with articles limited to the English language and publication in the last 15 years. Eligible articles were appraised using the QUADAS-2 framework, and given marked interstudy heterogeneity, the diagnostic outcomes were analyzed using a narrative approach.
Results: A total of ten studies were reviewed — retrospective and one prospective — and found to observe a moderate–high risk of bias. The studies revealed that PW-MRI offers beneficial diagnostic capabilities when compared to other MRI sequences and ability to detect significant diffusion–perfusion mismatches. However, PW-MRI was found to overestimate the degree of oligemia and ischemia in brain tissue. As ischemia does not always progress to infarction, thrombolytic treatment may be unnecessary in some cases and expose patients to adverse effects.
Conclusion: These findings indicate that PW-MRI should be considered for routine imaging as an adjunct to other MRI protocols and an alternative to CT thereby reducing ionizing radiation exposure.
| Original language | English |
|---|---|
| Pages (from-to) | 79-89 |
| Number of pages | 11 |
| Journal | Reports in Medical Imaging |
| Volume | 14 |
| DOIs | |
| Publication status | Published - 16 Nov 2021 |
Keywords
- perfusion–diffusion deficits, cross-sectional diagnostic imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Documents and Links
- Jaafari, O. et al (2021) Diagnostic value of perfusion-weighted magnetic resonance imaging as an adjunct to routine magnetic resonance protocols for adults presenting with acute ischemic stroke
© 2021 Jaafari et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)